| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 5.8% | +38% | $9,141,811 | +$2,380,447 | 3,841,097 | +35% | BlackRock, Inc. | 31 Mar 2025 |
| VANGUARD GROUP INC | 5.6% | $10,141,068 | 3,728,334 | The Vanguard Group | 30 Jun 2025 | |||
| PFIZER INC | 3.6% | $5,739,548 | 2,411,575 | Pfizer Inc. 13-5315170 | 31 Dec 2024 |
As of 30 Sep 2025, 109 institutional investors reported holding 25,150,264 shares of Cardiff Oncology, Inc. - Common Stock (CRDF). This represents 38% of the company’s total 66,577,393 outstanding shares.
The largest institutional shareholders of Cardiff Oncology, Inc. - Common Stock (CRDF) together control 35% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6% | 3,985,536 | +1.2% | 0% | $8,210,204 |
| VANGUARD GROUP INC | 5.4% | 3,588,933 | -3.7% | 0% | $7,393,202 |
| Laurion Capital Management LP | 3.7% | 2,465,872 | +37% | 0.69% | $5,079,696 |
| Pfizer Inc | 3.6% | 2,411,575 | 0% | 1.1% | $4,967,845 |
| BLAIR WILLIAM & CO/IL | 3.3% | 2,213,606 | -12% | 0.01% | $4,560,028 |
| ACORN CAPITAL ADVISORS, LLC | 2.9% | 1,962,084 | +39% | 2.1% | $4,041,893 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,543,320 | +3% | 0% | $3,180,068 |
| STATE STREET CORP | 1.7% | 1,146,359 | +1.8% | 0% | $2,361,500 |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 0.9% | 597,233 | +1009% | 0.02% | $1,230,300 |
| NORTHERN TRUST CORP | 0.78% | 519,752 | -28% | 0% | $1,070,690 |
| GOLDMAN SACHS GROUP INC | 0.68% | 454,726 | +496% | 0% | $936,736 |
| Bank of New York Mellon Corp | 0.52% | 347,485 | +4.1% | 0% | $715,819 |
| MORGAN STANLEY | 0.47% | 310,659 | -61% | 0% | $639,958 |
| NATIONAL BANK OF CANADA /FI/ | 0.31% | 208,700 | +652088% | 0% | $429,922 |
| UBS Group AG | 0.31% | 206,175 | +4.4% | 0% | $424,721 |
| TWO SIGMA INVESTMENTS, LP | 0.31% | 204,010 | -54% | 0% | $420,261 |
| Nuveen, LLC | 0.29% | 194,310 | -65% | 0% | $400,279 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.28% | 189,315 | 0% | 0% | $389,989 |
| JANE STREET GROUP, LLC | 0.24% | 161,928 | 0% | $333,572 | |
| XTX Topco Ltd | 0.23% | 156,161 | +20% | 0.02% | $321,692 |
| Avestar Capital, LLC | 0.21% | 140,469 | 0% | 0.02% | $289,366 |
| ROYAL BANK OF CANADA | 0.17% | 116,405 | -39% | 0% | $241,000 |
| AlphaCore Capital LLC | 0.17% | 109,926 | +8.2% | 0.01% | $226,448 |
| RENAISSANCE TECHNOLOGIES LLC | 0.15% | 101,800 | -22% | 0% | $209,708 |
| Cubist Systematic Strategies, LLC | 0.13% | 88,903 | 0% | $183,140 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 117,468 | $329,692 | +$45,568 | $2.81 | 5 |
| 2025 Q3 | 25,150,264 | $51,811,088 | -$9,699,944 | $2.06 | 109 |
| 2025 Q2 | 28,660,334 | $90,269,224 | -$11,262,617 | $3.15 | 114 |
| 2025 Q1 | 32,345,011 | $101,559,591 | +$10,196,279 | $3.14 | 116 |
| 2024 Q4 | 28,092,578 | $121,917,438 | +$50,159,876 | $4.34 | 117 |
| 2024 Q3 | 12,761,449 | $34,075,026 | -$900,038 | $2.67 | 83 |
| 2024 Q2 | 12,794,219 | $28,397,554 | +$5,434,902 | $2.22 | 89 |
| 2024 Q1 | 8,576,486 | $45,797,587 | +$17,619,137 | $5.34 | 75 |
| 2023 Q4 | 5,280,075 | $7,814,926 | -$209,486 | $1.48 | 53 |
| 2023 Q3 | 5,422,916 | $7,537,555 | -$761,483 | $1.39 | 55 |
| 2023 Q2 | 5,961,928 | $8,764,511 | -$1,396,407 | $1.47 | 48 |
| 2023 Q1 | 7,034,521 | $11,608,581 | -$750,291 | $1.65 | 50 |
| 2022 Q4 | 7,684,112 | $10,755,201 | -$321,468 | $1.40 | 53 |
| 2022 Q3 | 7,923,892 | $12,204,032 | -$1,958,723 | $1.54 | 48 |
| 2022 Q2 | 7,862,248 | $17,298,792 | -$14,116,920 | $2.20 | 49 |
| 2022 Q1 | 13,784,654 | $34,159,207 | -$29,172,144 | $2.48 | 78 |
| 2021 Q4 | 21,414,814 | $128,453,136 | +$2,410,627 | $6.01 | 78 |
| 2021 Q3 | 21,013,586 | $140,007,888 | -$33,563,840 | $6.66 | 84 |
| 2021 Q2 | 26,365,931 | $175,332,000 | +$10,071,177 | $6.65 | 83 |
| 2021 Q1 | 24,079,480 | $222,964,000 | -$73,062,531 | $9.26 | 69 |
| 2020 Q4 | 25,674,887 | $461,841,000 | +$144,054,588 | $17.99 | 74 |
| 2020 Q3 | 18,710,137 | $265,494,000 | +$207,896,302 | $14.19 | 61 |
| 2020 Q2 | 4,923,520 | $24,668,000 | +$24,667,956 | $5.01 | 22 |